Verastem Oncology (VSTM) Misses Q1 EPS by 79c

Verastem Oncology (NASDAQ: VSTM) reported Q1 EPS of ($0.79).

For earnings history and earnings-related data on Verastem Oncology (VSTM) click here.

You May Also Be Interested In

• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Phillips 66, Marathon Merger Talks Collapsed - Semafor